NCT06898333Recruiting
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Evaluating the Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink \& Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligible women undergoing mammography at BJC West County. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, the research questions and specific aims for this proposal are to: a) evaluate the baseline prevalence of LCS among LCS-eligible women; b) assess whether the Pink \& Pearl Campaign increases referrals and uptake/ completion of LCS among LCS-eligible women undergoing screening mammography; and c) evaluate individual and environmental factors influencing LCS uptake, and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 279 (estimated)
- First submitted
- 20 Mar 2025
- Start date
- 8 May 2025
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Lung cancer
- NCT number
- NCT06898333
What you commit to
- Study type: Observational
- Planned participants: 279
- From 8 May 2025 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Diagnosed with a serious health problem that will likely limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
- Subjects with symptoms of lung cancer should get a diagnostic CT scan
Other illness
- Unable or unwilling to get treatment if lung cancer is found
- Eligibility Criteria for Providers:
Age
- Older than 20 years of age
Who the study is looking for
- Undergoing screening mammography
- Between the ages of 50-80 years (inclusive)
- Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
- Can speak and understand English
- Ability to understand willingness to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Barnes-Jewish Hospital West County Coordinator of this site? Confirm its status | Creve Coeur | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.